Selenoprotein P is not elevated in gestational diabetes mellitus


Altinova A. E. , Iyidir O. T. , Ozkan C., Ors D., Ozturk M., GÜLBAHAR Ö. , ...Daha Fazla

GYNECOLOGICAL ENDOCRINOLOGY, cilt.31, sa.11, ss.874-876, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Konu: 11
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3109/09513590.2015.1103220
  • Dergi Adı: GYNECOLOGICAL ENDOCRINOLOGY
  • Sayfa Sayıları: ss.874-876

Özet

Selenoprotein P concentrations have been found to be associated with insulin resistance and elevated in patients with type 2 diabetes mellitus (DM). The aim of the present study was to investigate circulating selenoprotein P level and its possible relationship with metabolic parameters in gestational diabetes mellitus (GDM). Plasma selenoprotein P concentrations were measured in 30 pregnant women with GDM, 35 pregnant women without GDM and 22 healthy nonpregnant women. No difference in selenoprotein P levels was observed among the groups [6.2 (4.5-8.2), 7.9 (4.5-10.7) and 6.7 (5.3-9.1) ng/ml, respectively, p=0.69]. In pregnant women with and without GDM, selenoprotein P did not correlate with age, gestational age, prepregnancy body mass index (BMI), HbA1c, glucose concentrations at oral glucose tolerance test (OGTT), area under curve (AUC) glucose, total cholesterol, LDL cholesterol and triglycerides levels (p>0.05). But, there were statistically significant correlations between selenoprotein P and current BMI (r=-0.28, p=0.04) and HDL cholesterol levels (r=0.43, p=0.01). We found that selenoprotein P concentrations are not elevated in women with GDM but associated with BMI and HDL cholesterol.